📑Contracte basat en l'Acord marc CSC F 1/21 de subministrament del medicament Adalimumab
Procurement process summary
This process is to purchase Contracte basat en l'Acord marc CSC F 1/21 de subministrament del medicament Adalimumab.
This contract was awarded by 🇪🇸 Gestió de Serveis Sanitaris (GSS) for an amount of EUR 99,256 to 1 supplier. It was published on 2021-11-02 through selective
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇸 Gestió de Serveis Sanitaris (GSS) Buying unitnot reported Publication date2021-11-02 Contest statusnot reported Descriptionnot reportedAwards
This award was granted to FRESENIUS KABI ESPAÑA, S.A.U. by Gestió de Serveis Sanitaris (GSS) for an amount of EUR 99,256. The procurement process was conducted through selective for the category of goods. This is award number 1.
| Supplier | Amount | Award number |
|---|---|---|
| 🇪🇸 FRESENIUS KABI ESPAÑA, S.A.U. | EUR 99,256 | 1 |
Market context and opportunities
The execution of this contract allows the entity Gestió de Serveis Sanitaris (GSS) to fulfill its public service objectives efficiently.
The selective purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberES_ocds-70d2nz-e14ea336-f64d-421b-a300-04eefdc951eb-award-1Publication date2021-11-02Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityselectiveMethod details7Statusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
